Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Gu, Zhennan ^a,b   Suburu, Janel ^b   Chen, Haiqin ^a   Chen, Yong Q ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; LINOLENIC ACID; LINOLEOYL COENZYME A DESATURASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR NRF2; G PROTEIN COUPLED RECEPTOR; GLYCEROPHOSPHOLIPID;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BIOTRANSFORMATION; CANCER PREVENTION; CANCER RISK; DIETARY INTAKE; DRUG MECHANISM; FATTY ACID METABOLISM; HUMAN; IN VITRO STUDY; NONHUMAN; PROSTATE CANCER; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; CELL MEMBRANE; MALE; METABOLISM; PROSTATIC NEOPLASMS; PROSTATE TUMOR;

CELL MEMBRANE; FATTY ACIDS, OMEGA-3; GLYCEROPHOSPHOLIPIDS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84878736557     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/824563     Document Type: Review

References (119)

1. Bang H. O., Dyerberg J., Nielsen A. B., Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. The Lancet 1971 1 7710 1143 1145 2-s2.0-0015211669
2. Dyerberg J., Bang H. O., Hjorne N., Fatty acid composition of the plasma lipids in Greenland Eskimos. The American Journal of Clinical Nutrition 1975 28 9 958 966 2-s2.0-0016809013
3. Oh D. Y., Talukdar S., Bae E. J., Imamura T., Morinaga H., Fan W., Li P., Lu W. J., Watkins S. M., Olefsky J. M., GPR120 is an Omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010 142 5 687 698 2-s2.0-77956165390 10.1016/j.cell.2010.07.041
4. Ariel A., Serhan C. N., Resolvins and protectins in the termination program of acute inflammation. Trends in Immunology 2007 28 4 176 183 2-s2.0-33947500462 10.1016/j.it.2007.02.007 (Pubitemid 46467520)
5. Daley C. A., Abbott A., Doyle P. S., Nader G. A., Larson S., A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutrition Journal 2010 9 1, article 10 2-s2.0-77949470493 10.1186/1475-2891-9-10
6. Bernert J. T. Jr., Sprecher H., Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids. Biochimica et Biophysica Acta 1975 398 3 354 363 2-s2.0-0016766826
7. Berquin I. M., Edwards I. J., Kridel S. J., Chen Y. Q., Polyunsaturated fatty acid metabolism in prostate cancer. Cancer and Metastasis Reviews 2011 30 3-4 295 309
8. Swinnen J. V., Brusselmans K., Verhoeven G., Increased lipogenesis in cancer cells: new players, novel targets. Current Opinion in Clinical Nutrition and Metabolic Care 2006 9 4 358 365 2-s2.0-33746291023 10.1097/01.mco. 0000232894.28674.30 (Pubitemid 44101970)
9. Kuhajda F. P., Fatty acid synthase and cancer: new application of an old pathway. Cancer Research 2006 66 12 5977 5980 2-s2.0-33745728461 10.1158/0008-5472.CAN-05-4673
10. Menendez J. A., Lupu R., Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature Reviews Cancer 2007 7 10 763 777 2-s2.0-34748912615 10.1038/nrc2222 (Pubitemid 47469806)
11. Suburu J., Chen Y. Q., Lipids and prostate cancer. Prostaglandins and Other Lipid Mediators 2012 98 1 10
12. Burdge G. C., Calder P. C., Conversion of α -linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development 2005 45 5 581 597 2-s2.0-27244445146 10.1051/rnd:2005047 (Pubitemid 41511883)
13. Williams C. M., Burdge G., Long-chain n-3 PUFA: plant v. marine sources. Proceedings of the Nutrition Society 2006 65 1 42 50 2-s2.0-32944467555 10.1079/PNS2005473 (Pubitemid 43259983)
14. Pawlosky R. J., Hibbeln J. R., Novotny J. A., Salem N., Physiological compartmental analysis of α -linolenic acid metabolism in adult humans. Journal of Lipid Research 2001 42 8 1257 1265 2-s2.0-0034884757 (Pubitemid 32744249)
15. Simopoulos A. P., Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukotrienes and Essential Fatty Acids 1999 60 5-6 421 429 2-s2.0-0032802906 10.1016/S0952-3278(99)80023-4 (Pubitemid 29401803)
16. Simopoulos A. P., The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine and Pharmacotherapy 2002 56 8 365 379 2-s2.0-0036776120 10.1016/S0753-3322(02)00253-6 (Pubitemid 35232740)
17. Berquin I. M., Min Y., Wu R., Wu J., Perry D., Cline J. M., Thomas M. J., Thornburg T., Kulik G., Smith A., Edwards I. J., D'Agostino R., Zhang H., Wu H., Kang J. X., Chen Y. Q., Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. Journal of Clinical Investigation 2007 117 7 1866 1875 2-s2.0-34447121230 10.1172/JCI31494 (Pubitemid 47036320)
18. Calviello G., Resci F., Serini S., Piccioni E., Toesca A., Boninsegna A., Monego G., Ranelletti F. O., Palozza P., Docosahexaenoic acid induces proteasome-dependent degradation of β -catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis 2007 28 6 1202 1209 2-s2.0-34447330713 10.1093/carcin/bgl254 (Pubitemid 47062678)
19. Sun H., Berquin I. M., Owens R. T., O'Flaherty J. T., Edwards I. J., Peroxisome proliferator-activated receptor γ -mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Research 2008 68 8 2912 2919 2-s2.0-42349114775 10.1158/0008-5472.CAN-07- 2305 (Pubitemid 351556291)
20. Berquin I. M., Edwards I. J., Chen Y. Q., Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Letters 2008 269 2 363 377 2-s2.0-51349137876 10.1016/j.canlet.2008.03.044
21. Chen Y. Q., Edwards I. J., Kridel S. J., Thornburg T., Berquin I. M., Dietary fat-gene interactions in cancer. Cancer Metastasis Reviews 2007 26 535 551 (Pubitemid 350115105)
22. Wang S., Wu J., Suburu J., Gu Z., Cai J., Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Carcinogenesis 2012 33 404 412
23. Carroll K. K., Dietary fat and cancer: specific action or caloric effect? Journal of Nutrition 1986 116 6 1130 1132 2-s2.0-0022526890 (Pubitemid 16069818)
24. Gerber M., Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. British Journal of Nutrition 2012 107 Supplement 2 228 239
25. Terry P. D., Rohan T. E., Wolk A., Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. The American Journal of Clinical Nutrition 2003 77 3 532 543 2-s2.0-0037373087 (Pubitemid 36258559)
26. MacLean C. H., Newberry S. J., Mojica W. A., Khanna P., Issa A. M., Suttorp M. J., Lim Y. W., Traina S. B., Hilton L., Garland R., Morton S. C., Effects of omega-3 fatty acids on cancer risk: a systematic review. Journal of the American Medical Association 2006 295 4 403 415 2-s2.0-31344478294 10.1001/jama.295.4.403 (Pubitemid 43144977)
27. Chen Y. Q., Berquin I. M., Daniel L. W., Edwards I. J., O'Flaherty J. T., Thomas M. J., Tooze J. A., Wykle B., Omega-3 fatty acids and cancer risk. Journal of the American Medical Association 2006 296 3 278 282 2-s2.0-33746044878 10.1001/jama.296.3.282-a (Pubitemid 44079310)
28. Schumacher M. C., Laven B., Petersson F., Cederholm T., Onelöv E., Ekman P., Brendler C., A comparative study of tissue ω -6 and ω -3 polyunsaturated fatty acids (PUFA) in benign and malignant pathologic stage pT2a radical prostatectomy specimens. Urologic Oncology 2013 31 3 318 324 2-s2.0-79952515400 10.1016/j.urolonc.2011.01.014
29. Williams C. D., Whitley B. M., Hoyo C., Grant D. J., Iraggi J. D., A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutrition Research 2011 31 1 1 8
30. Brown M. D., Hart C., Gazi E., Gardner P., Lockyer N., Clarke N., Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer. British Journal of Cancer 2010 102 2 403 413 2-s2.0-75549085309 10.1038/sj.bjc.6605481
31. Ritch C. R., Wan R. L., Stephens L. B., Taxy J. B., Huo D., Gong E. M., Zagaja G. P., Brendler C. B., Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. Journal of Urology 2007 177 1 97 101 2-s2.0-33845309431 10.1016/j.juro.2006.08.105 (Pubitemid 44879447)
32. Sawada N., Inoue M., Iwasaki M., Sasazuki S., Shimazu T., Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology 2012 142 1468 1475
33. Sasazuki S., Inoue M., Iwasaki M., Sawada N., Shimazu T., Yamaji T., Takachi R., Tsugane S., Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan Public Health Center-based prospective study. International Journal of Cancer 2011 129 7 1718 1729 2-s2.0-79960913730 10.1002/ijc.25802
34. Chavarro J. E., Stampfer M. J., Li H., Campos H., Kurth T., Ma J., A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiology Biomarkers and Prevention 2007 16 7 1364 1370 2-s2.0-34447515521 10.1158/1055-9965.EPI-06-1033 (Pubitemid 47076865)
35. Szymanski K. M., Wheeler D. C., Mucci L. A., Fish consumption and prostate cancer risk: a review and meta-analysis. The American Journal of Clinical Nutrition 2010 92 5 1223 1233 2-s2.0-78149254382 10.3945/ajcn.2010. 29530
36. Kobayashi N., Barnard R. J., Henning S. M., Elashoff D., Reddy S. T., Cohen P., Leung P., Hong-Gonzalez J., Freedland S. J., Said J., Gui D., Seeram N. P., Popoviciu L. M., Bagga D., Heber D., Glaspy J. A., Aronson W. J., Effect of altering dietary ω -6/ ω -3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E 2. Clinical Cancer Research 2006 12 15 4662 4670 2-s2.0-33748090269 10.1158/1078-0432.CCR-06-0459 (Pubitemid 44297819)
37. Brown M. D., Hart C. A., Gazi E., Bagley S., Clarke N. W., Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. British Journal of Cancer 2006 94 6 842 853 2-s2.0-33645296034 10.1038/sj.bjc.6603030
38. Chabot M. C., Schmitt J. D., Bullock B. C., Wykle R. L., Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. Biochimica et Biophysica Acta 1987 922 2 214 220 2-s2.0-0023662075
39. Picq M., Chen P., Perez M., Michaud M., Vericel E., DHA metabolism: targeting the brain and lipoxygenation. Molecular Neurobiology 2010 42 48 51
40. Gu Z., Wu J., Wang S., Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells. Carcinogenesis 2013 10.1093/carcin/bgt147
41. Wassall S. R., Stillwell W., Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chemistry and Physics of Lipids 2008 153 1 57 63 2-s2.0-43049170473 10.1016/j.chemphyslip.2008.02.010
42. Eldho N. V., Feller S. E., Tristram-Nagle S., Polozov I. V., Gawrisch K., Polyunsaturated docosahexaenoic vs docosapentaenoic acid-Differences in lipid matrix properties from the loss of one double bond. Journal of the American Chemical Society 2003 125 21 6409 6421 2-s2.0-0037837613 10.1021/ja029029o (Pubitemid 36605409)
43. Mitchell D. C., Niu S. L., Litman B. J., Quantifying the differential effects of DHA and DPA on the early events in visual signal transduction. Chemistry and Physics of Lipids 2012 165 393 400
44. Turk H. F., Barhoumi R., Chapkin R. S., Alteration of EGFR spatiotemporal dynamics suppresses signal transduction. PLoS One 2012 7 6 e39682 10.1371/journal.pone.0039682
45. Datta S. R., Dudek H., Xu T., Masters S., Haian F., Gotoh Y., Greenberg M. E., Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell 1997 91 2 231 241 2-s2.0-0030702123 10.1016/S0092-8674(00)80405-5 (Pubitemid 27456390)
46. Maehama T., Dixon J. E., The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. Journal of Biological Chemistry 1998 273 22 13375 13378 2-s2.0-0032577699 10.1074/jbc.273.22.13375 (Pubitemid 28268370)
47. Engelman J. A., Luo J., Cantley L. C., The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Reviews Genetics 2006 7 8 606 619 2-s2.0-33746257209 10.1038/nrg1879 (Pubitemid 44100518)
48. Franke T. F., PI3K/Akt: getting it right matters. Oncogene 2008 27 50 6473 6488 2-s2.0-54949109808 10.1038/onc.2008.313
49. Hu Y., Sun H., Owens R. T., Gu Z., Wu J., Chen Y. Q., O'Flaherty J. T., Edwards I. J., Syndecan-1-dependent suppression of PDK1/Akt/Bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Neoplasia 2010 12 10 826 836 2-s2.0-77957807607 10.1593/neo.10586
50. Schley P. D., Jijon H. B., Robinson L. E., Field C. J., Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Research and Treatment 2005 92 2 187 195 2-s2.0-21644462730 10.1007/s10549-005-2415-z (Pubitemid 40933584)
51. Toit-Kohn J. L. D., Louw L., Engelbrecht A. M., Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. Journal of Nutritional Biochemistry 2009 20 2 106 114 2-s2.0-58149134851 10.1016/j.jnutbio.2007.12.005
52. DuBois R. N., Abramson S. B., Crofford L., Gupta R. A., Simon L. S., Van De Putte L. B. A., Lipsky P. E., Cyclooxygenase in biology and disease. FASEB Journal 1998 12 12 1063 1073 2-s2.0-0031689543 (Pubitemid 28418937)
53. Pidgeon G. P., Lysaght J., Krishnamoorthy S., Reynolds J. V., O'Byrne K., Nie D., Honn K. V., Lipoxygenase metabolism: roles in tumor progression and survival. Cancer and Metastasis Reviews 2007 26 3-4 503 524 2-s2.0-36149000163 10.1007/s10555-007-9098-3 (Pubitemid 350115127)
54. Ye Y. N., Wu W. K. K., Shin V. Y., Bruce I. C., Wong B. C. Y., Cho C. H., Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis 2005 26 4 827 834 2-s2.0-17844390400 10.1093/carcin/bgi012 (Pubitemid 41214346)
55. Sharma B. K., Pilania P., Singh P., Modeling of cyclooxygenase-2 and 5-lipooxygenase inhibitory activity of apoptosis-inducing agents potentially useful in prostate cancer chemotherapy: derivatives of diarylpyrazole. Journal of Enzyme Inhibition and Medicinal Chemistry 2009 24 2 607 615 2-s2.0-68049114614 10.1080/14756360802318878
56. Diederich M., Sobolewski C., Cerella C., Dicato M., Ghibelli L., The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. International Journal of Cell Biology 2010 2-s2.0-77955939152 10.1155/2010/215158 215158
57. Wang M. T., Honn K. V., Nie D., Cyclooxygenases, prostanoids, and tumor progression. Cancer and Metastasis Reviews 2007 26 3-4 525 534 2-s2.0-36148978529 10.1007/s10555-007-9096-5 (Pubitemid 350115125)
58. Menter D. G., Schilsky R. L., DuBois R. N., Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clinical Cancer Research 2010 16 5 1384 1390 2-s2.0-77649090075 10.1158/1078-0432.CCR-09-0788
59. Reese A. C., Fradet V., Witte J. S., ω -3 Fatty acids, genetic variants in COX-2 and prostate cancer. Journal of Nutrigenetics and Nutrigenomics 2009 2 3 149 158 2-s2.0-70349258243 10.1159/000235565
60. Bang H. O., Dyerberg J., Hjorne N., The composition of food consumed by Greenland Eskimos. Acta Medica Scandinavica 1976 200 1-2 69 73 2-s2.0-0017185755
61. Dyerberg J., Bang H. O., Stoffersen E., Moncada S., Vane J. R., Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? The Lancet 1978 2 8081 117 119 2-s2.0-0018152134 (Pubitemid 8373454)
62. Serhan C. N., Clish C. B., Brannon J., Colgan S. P., Chiang N., Gronert K., Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. Journal of Experimental Medicine 2000 192 8 1197 1204 2-s2.0-0034675852 10.1084/jem.192.8.1197
63. Hasturk H., Kantarci A., Ohira T., Arita M., Ebrahimi N., Chiang N., Petasis N. A., Levy B. D., Serhan C. N., Van Dyke T. E., RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB Journal 2006 20 2 401 403 2-s2.0-33644928418 10.1096/fj.05-4724fje (Pubitemid 46671185)
64. Connor K. M., Sangiovanni J. P., Lofqvist C., Aderman C. M., Chen J., Higuchi A., Hong S., Pravda E. A., Majchrzak S., Carper D., Hellstrom A., Kang J. X., Chew E. Y., Salem N., Serhan C. N., Smith L. E. H., Increased dietary intake of ω -3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nature Medicine 2007 13 7 868 873 2-s2.0-34447119437 10.1038/nm1591 (Pubitemid 47038185)
65. Ogawa S., Urabe D., Yokokura Y., Arai H., Arita M., Inoue M., Total synthesis and bioactivity of resolvin E2. Organic Letters 2009 11 16 3602 3605 2-s2.0-68949122370 10.1021/ol901350g
66. Weylandt K. H., Chiu C. Y., Gomolka B., Waechter S. F., Wiedenmann B., Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins and Other Lipid Mediators 2012 97 73 82
67. Sun Y. P., Oh S. F., Uddin J., Yang R., Gotlinger K., Campbell E., Colgan S. P., Petasis N. A., Serhan C. N., Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. Journal of Biological Chemistry 2007 282 13 9323 9334 2-s2.0-34248233132 10.1074/jbc.M609212200 (Pubitemid 47104612)
68. Park C. K., Xu Z. Z., Liu T., Lu N., Serhan C. N., Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. Journal of Neuroscience 2011 31 18433 18438
69. Zhao Y., Calon F., Julien C., Winkler J. W., Petasis N. A., Lukiw W. J., Bazan N. G., Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR γ -mediated mechanisms in Alzheimer's disease models. PLoS ONE 2011 6 1 2-s2.0-79251559674 10.1371/journal.pone. 0015816 e15816
70. Tazoe H., Otomo Y., Kaji I., Tanaka R., Karaki S. I., Kuwahara A., Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. Journal of Physiology and Pharmacology 2008 59 supplement 2 251 262 2-s2.0-51449119654
71. Wang J., Wu X., Simonavicius N., Tian H., Ling L., Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. Journal of Biological Chemistry 2006 281 45 34457 34464 2-s2.0-33845954973 10.1074/jbc.M608019200 (Pubitemid 46036653)
72. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., Fujino M., Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature 2003 422 6928 173 176 2-s2.0-0037434991 10.1038/nature01478 (Pubitemid 36362750)
73. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., Tsujimoto G., Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine 2005 11 1 90 94 2-s2.0-13444263540 10.1038/nm1168 (Pubitemid 40215843)
74. Suzuki M., Takaishi S., Nagasaki M., Onozawa Y., Iino I., Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. Journal of Biological Chemistry 2013 288 10684 10691
75. Briscoe C. P., Tadayyon M., Andrews J. L., Benson W. G., Chambers J. K., Eilert M. M., Ellis C., Elshourbagy N. A., Goetz A. S., Minnick D. T., Murdock P. R., Sauls H. R., Shabon U., Spinage L. D., Strum J. C., Szekeres P. G., Tan K. B., Way J. M., Ignar D. M., Wilson S., Muir A. I., The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. Journal of Biological Chemistry 2003 278 13 11303 11311 2-s2.0-0037838892 10.1074/jbc.M211495200 (Pubitemid 36792687)
76. Hardy S., St-Onge G. G., Joly E., Langelier Y., Prentki M., Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. Journal of Biological Chemistry 2005 280 14 13285 13291 2-s2.0-17144421545 10.1074/jbc.M410922200 (Pubitemid 40517213)
77. Alquier T., Peyot M. L., Latour M. G., Kebede M., Sorensen C. M., Gesta S., Kahn C. R., Smith R. D., Jetton T. L., Metz T. O., Prentki M., Poitout V., Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets. Diabetes 2009 58 11 2607 2615 2-s2.0-70350561694 10.2337/db09-0362
78. Nakamoto K., Nishinaka T., Matsumoto K., Kasuya F., Mankura M., Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system. Brain Research 2012 1432 74 83
79. Ma D., Zhang M., Larsen C. P., Xu F., Hua W., Yamashima T., Mao Y., Zhou L., DHA promotes the neuronal differentiation of rat neural stem cells transfected with GPR40 gene. Brain Research 2010 1330 1 8 2-s2.0-77955913812 10.1016/j.brainres.2010.03.002
80. Ichimura A., Hirasawa A., Poulain-Godefroy O., Bonnefond A., Hara T., Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012 483 350 354
81. Oh D. Y., Olefsky J. M., Omega 3 fatty acids and GPR120. Cell Metabolism 2012 15 564 565
82. Kawai T., Akira S., TLR signaling. Cell Death and Differentiation 2006 13 5 816 825 2-s2.0-33645960706 10.1038/sj.cdd.4401850
83. Ridnour L. A., Cheng R. Y., Switzer C. H., Heinecke J. L., Ambs S., Molecular Pathways: toll-like receptors in the tumor microenvironment: poor prognosis or new therapeutic opportunity. Clinical Cancer Research 2012 19 6 1340 1346 10.1158/1078-0432.CCR-12-0408
84. Krishnan J., Lee G., Choi S., Drugs targeting toll-like receptors. Archives of Pharmacal Research 2009 32 11 1485 1502 2-s2.0-72049122659 10.1007/s12272-009-2100-6
85. Paone A., Starace D., Galli R., Padula F., De Cesaris P., Filippini A., Ziparo E., Riccioli A., Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC- α -dependent mechanism. Carcinogenesis 2008 29 7 1334 1342 2-s2.0-49349103910 10.1093/carcin/bgn149
86. Zheng S. L., Augustsson-Bälter K., Chang B., Hedelin M., Li L., Adami H. O., Bensen J., Li G., Johnasson J. E., Turner A. R., Adams T. S., Meyers D. A., Isaacs W. B., Xu J., Grönberg H., Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the cancer prostate in Sweden study. Cancer Research 2004 64 8 2918 2922 2-s2.0-8444235603 10.1158/0008-5472.CAN-03-3280 (Pubitemid 38500633)
87. Väisänen M. R., Väisänen T., Jukkola-Vuorinen A., Vuopala K. S., Desmond R., Selander K. S., Vaarala M. H., Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate 2010 70 8 817 824 2-s2.0-77952295948 10.1002/pros.21115
88. Panigrahy D., Kaipainen A., Greene E. R., Huang S., Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer Metastasis Reviews 2010 29 4 723 735 2-s2.0-79952196577
89. Wang Z., Liu D., Wang F., Liu S., Zhao S., Saturated fatty acids activate microglia via Toll-like receptor 4/NF-kappaB signalling. British Journal of Nutrition 2012 107 229 241
90. Robbins G. T., Nie D., PPAR gamma, bioactive lipids, and cancer progression. Frontiers in Bioscience 2012 17 1816 1834
91. Murff H. J., Shu X. O., Li H., Yang G., Wu X., Cai H., Wen W., Gao Y. T., Zheng W., Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. International Journal of Cancer 2011 128 6 1434 1441 2-s2.0-79551469665 10.1002/ijc.25703
92. Sun H., Hu Y., Gu Z., Owens R. T., Chen Y. Q., Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. Carcinogenesis 2011 32 1518 1524
93. Edwards I. J., Berquin I. M., Sun H., O'Flaherty J. T., Daniel L. W., Thomas M. J., Rudel L. L., Wylde R. L., Chen Y. Q., Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin. Clinical Cancer Research 2004 10 24 8275 8283 2-s2.0-11144247920 10.1158/1078-0432.CCR-04-1357 (Pubitemid 40053387)
94. Sun H., Berquin I. M., Edwards I. J., Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells. Cancer Research 2005 65 10 4442 4447 2-s2.0-20144363220 10.1158/0008-5472.CAN-04-4200 (Pubitemid 40775684)
95. Sun H., Hu Y., Gu Z., Wilson M. D., Chen Y. Q., Rudel L. L., Willingham M. C., Edwards I. J., Endogenous synthesis of n-3 polyunsaturated fatty acids in Fat-1 mice is associated with increased mammary gland and liver Syndecan-1. PLoS ONE 2011 6 5 2-s2.0-79957794695 10.1371/journal.pone.0020502 e20502
96. Teng Y. H., Aquino R. S., Park P. W., Molecular functions of syndecan-1 in disease. Matrix Biology 2012 31 3 16
97. Ishikawa T., Kramer R. H., Sdc1 negatively modulates carcinoma cell motility and invasion. Experimental Cell Research 2010 316 6 951 965 2-s2.0-77649187760 10.1016/j.yexcr.2009.12.013
98. Kiviniemi J., Kallajoki M., Kujala I., Matikainen M. T., Alanen K., Jalkanen M., Salmivirta M., Altered expression of syndecan-1 in prostate cancer. APMIS 2004 112 2 89 97 2-s2.0-1642523686 10.1111/j.1600-0463.2004.apm1120202.x (Pubitemid 38406681)
99. Chen D., Adenekan B., Chen L., Vaughan E. D., Gerald W., Feng Z., Knudsen B. S., Syndecan-1 expression in locally invasive and metastatic prostate cancer. Urology 2004 63 2 402 407 2-s2.0-1242296367 10.1016/j.urology.2003.08. 036 (Pubitemid 38234455)
100. Zellweger T., Ninck C., Mirlacher M., Annefeld M., Glass A. G., Gasser T. C., Mihatsch M. J., Gelmann E. P., Bubendorf L., Tissue microarray analysis reveals prognostic significance of syndecan-I expression in prostate cancer. Prostate 2003 55 1 20 29 2-s2.0-0037384548 10.1002/pros.10209 (Pubitemid 36397741)
101. Edwards I. J., Sun H., Hu Y., Berquin I. M., O'Flaherty J. T., Cline J. M., Rudel L. L., Chen Y. Q., In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids. Journal of Biological Chemistry 2008 283 26 18441 18449 2-s2.0-49649104813 10.1074/jbc.M802107200
102. Corsetto P. A., Montorfano G., Zava S., Jovenitti I. E., Cremona A., Rizzo A. M., Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids in Health and Disease 2011 10, article 73 2-s2.0-79955830837 10.1186/1476-511X-10-73
103. Ewaschuk J. B., Newell M., Field C. J., Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells. Lipids 2012 47 1019 1030
104. Lee J. Y., Zhao L., Hwang D. H., Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutrition Reviews 2010 68 1 38 61 2-s2.0-77649209729 10.1111/j.1753-4887. 2009.00259.x
105. Mitsuishi Y., Motohashi H., Yamamoto M., The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Frontiers in Oncology 2012 2, article 200 10.3389/fonc.2012.00200
106. Wang H., Khor T. O., Saw C. L. L., Lin W., Wu T., Huang Y., Kong A. N. T., Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Molecular Pharmaceutics 2010 7 6 2185 2193 2-s2.0-78649449021 10.1021/mp100199m
107. Zhang P., Singh A., Yegnasubramanian S., Esopi D., Kombairaju P., Bodas M., Wu H., Bova S. G., Biswal S., Loss of kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Molecular Cancer Therapeutics 2010 9 2 336 346 2-s2.0-76649089973 10.1158/1535-7163.MCT-09-0589
108. Singh A., Boldin-Adamsky S., Thimmulappa R. K., Rath S. K., Ashush H., Coulter J., Blackford A., Goodman S. N., Bunz F., Watson W. H., Gabrielson E., Feinstein E., Biswal S., RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Research 2008 68 19 7975 7984 2-s2.0-54249087596 10.1158/0008-5472.CAN-08-1401
109. Gao L., Wang J., Sekhar K. R., Yin H., Yared N. F., Schneider S. N., Sasi S., Dalton T. P., Anderson M. E., Chan J. Y., Morrow J. D., Freeman M. L., Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. Journal of Biological Chemistry 2007 282 4 2529 2537 2-s2.0-34047273206 10.1074/jbc.M607622200 (Pubitemid 47076775)
110. Ishikado A., Nishio Y., Morino K., Ugi S., Kondo H., Makino T., Kashiwagi A., Maegawa H., Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochemical and Biophysical Research Communications 2010 402 1 99 104 2-s2.0-78049269927 10.1016/j.bbrc.2010.09.124
111. Wang H., Khor T. O., Saw C. L. L., Lin W., Wu T., Huang Y., Kong A. N. T., Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. Molecular Pharmaceutics 2010 7 6 2185 2193 2-s2.0-78649449021 10.1021/mp100199m
112. Magbanua M. J., Roy R., Sosa E. V., Weinberg V., Federman S., Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One 2011 6 9 e24004 10.1371/journal.pone.0024004
113. 2+ signaling. Cell Calcium 2006 40 3 261 275 2-s2.0-33745976773 10.1016/j.ceca.2006.05.002 (Pubitemid 44063856)
114. Matta J. A., Miyares R. L., Ahern G. P., TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. Journal of Physiology 2007 578 2 397 411 2-s2.0-33846230027 10.1113/jphysiol.2006.121988 (Pubitemid 46092205)
115. Parnas M., Peters M., Minke B., Linoleic acid inhibits TRP channels with intrinsic voltage sensitivity: implications on the mechanism of linoleic acid action. Channels 2009 3 3 164 166 2-s2.0-79959368500
116. Leonelli M., Graciano M. F., Britto L. R., TRP channels, omega-3 fatty acids, and oxidative stress in neurodegeneration: from the cell membrane to intracellular cross-links. Brazilian Journal of Medical and Biological Research 2011 44 1088 1096
117. Ye S., Tan L., Ma J., Shi Q., Li J., Polyunsaturated docosahexaenoic acid suppresses oxidative stress induced endothelial cell calcium influx by altering lipid composition in membrane caveolar rafts. Prostaglandins Leukotrienes and Essential Fatty Acids 2010 83 1 37 43 2-s2.0-77953534230 10.1016/j.plefa.2010. 02.002
118. 2+ homeostasis of advanced prostate cancer cells. Biochimica et Biophysica Acta 2009 1793 6 1105 1109 2-s2.0-67349262774 10.1016/j.bbamcr.2009.01.009
119. 2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels. Journal of Biological Chemistry 2013 288 255 263